aluminum sulfate has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfonso, S; Areces, F; Cepeda, M; Chong, E; Crombet, T; de la Torre, AV; Flores, YI; García, E; González, Z; Guerra, PP; Hernández, AM; Hernández, M; Macías, AE; Mazorra, Z; Mendoza, IC; Ortiz, RA; Pérez, K; Pérez, R; Santiesteban, ER; Toledo, D; Valdés-Zayas, A; Vázquez, AM; Viada, CE | 1 |
| Aguirre, F; Alfonso, S; Alonso, DF; Barroso, Mdel C; de la Torre, A; Diaz, RM; Gabri, MR; Gómez, RE; Hernández, AM; Macias, AE; Pérez, K; Perez, R; Rodríguez, JL; Santiesteban, E; Suárez, E; Toledo, D; Vazquez, AM; Viada, C | 1 |
2 trial(s) available for aluminum sulfate and Lung Neoplasms
| Article | Year |
|---|---|
A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients.
Topics: Adjuvants, Immunologic; Alum Compounds; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cancer Vaccines; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Female; G(M3) Ganglioside; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Staging; Placebos; Proportional Hazards Models; Treatment Outcome | 2014 |
1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Alum Compounds; Animals; Antibodies, Anti-Idiotypic; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Gangliosides; Humans; Lung Neoplasms; Male; Mice; Middle Aged; Neoplasm Staging; Survival Analysis | 2007 |